Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Prescott Group Capital Management L.L.C.

Prescott Group Capital Management L.L.C. increased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) by 33.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 361,750 shares of the company’s stock after buying an additional 90,000 shares during the quarter. Prescott Group Capital Management L.L.C.’s holdings in Ginkgo Bioworks were worth $3,552,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. PDT Partners LLC acquired a new position in shares of Ginkgo Bioworks in the 3rd quarter worth approximately $1,199,000. Erste Asset Management GmbH acquired a new position in Ginkgo Bioworks in the third quarter worth approximately $4,075,000. Jacobs Levy Equity Management Inc. acquired a new position in Ginkgo Bioworks in the third quarter worth approximately $2,282,000. BNP Paribas Financial Markets bought a new position in shares of Ginkgo Bioworks in the third quarter valued at $1,287,000. Finally, Verition Fund Management LLC acquired a new stake in shares of Ginkgo Bioworks during the 3rd quarter valued at $792,000. 78.63% of the stock is currently owned by institutional investors and hedge funds.

Ginkgo Bioworks Stock Down 5.4 %

Shares of Ginkgo Bioworks stock opened at $7.82 on Friday. The stock’s fifty day moving average is $11.41 and its 200-day moving average is $9.41. The firm has a market capitalization of $449.20 million, a PE ratio of -0.60 and a beta of 1.23. Ginkgo Bioworks Holdings, Inc. has a 12-month low of $5.26 and a 12-month high of $51.20.

Ginkgo Bioworks Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.